Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Apr 16, 2015
Product R&D
Astellas opts for PR1
Astellas acquires an option to license first-in-class mAb for AML
BioCentury | Mar 5, 2015
Distillery Techniques
Techniques: Diagnostic markers of relapsing multiple sclerosis (MS)
BioCentury | Jul 12, 2010
Strategy
Kamada's Liquidity Event
Kamada's Glassia provides a liquid option for alpha 1-antitrypsin deficiency
Items per page:
1 - 10 of 14